Skip to content
Study details
Enrolling now

Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions

University of Chicago
NCT IDNCT05166694ClinicalTrials.gov data as of Apr 2026
Target enrollment

1,300

Study length

about 4.9 years

Ages

18+

Locations

1 site in IL

About this study

This trial is testing whether a consultation with a Personalized Therapeutics Clinic, or PTC, will help participants lower the risk for side effects (drug-drug interactions and drug-gene interactions) when taking many medications. The PTC will test your genes to gather information about your health that may help guide prescribing advice and offer you new information about your prescriptions. Doctors leading it will look for variations in your genes that may suggest that you are at greater risk of having side effects or a greater chance of benefiting from certain medications.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Drug-Drug Interaction Profile
  • 2.Drug-Gene Interaction Profile
  • 3.Standard of Care

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low5%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Secondary: Rate of Reported Adverse Events as Assessed by Clinical Records

Body systems

Oncology